½ÃÀ庸°í¼­
»óǰÄÚµå
1787924

¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø : Á¦Ç°º°, Àç·áº°, ¾àÁ¦ À¯Çüº°, À¯Åë ä³Îº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2032³â)

Multi-Dose Packaging System Market Forecasts to 2032 - Global Analysis By Product (Blister Packs, Pouches, Bottles, Sachets, Vials, Jars, Tubes and Other Products), Material, Drug Type, Distribution Channel, Technology, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀåÀº 2025³â 37¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È CAGR 8.1%¸¦ ³ªÅ¸³»¸ç 2032³â¿¡´Â 65¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛÀ̶ó´Â ÀǾàǰ Æ÷Àå ±â¼úÀº ´ÜÀÏ ¿ë±â¿¡ ¿©·¯ ¹ø ¾à¹°À» ³Ö±â À§ÇØ ¸¸µé¾îÁý´Ï´Ù. ƯÈ÷ ¸¸¼º Áúȯ ȯÀÚ, º´¿ø ¹× º¹Áö ½Ã¼³°ú °°Àº ȯ°æ¿¡¼­ º¹¿ë ¾îµåÈ÷¾î·±½º¸¦ ³ôÀÌ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº ³¯Â¥¿Í ½Ã°£¿¡ µû¶ó º¹¿ë·®À» ¹èÄ¡ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ Åõ¾à ´©ÃâÀ̳ª Åõ¾à ½Ç¼öÀÇ °¡´É¼ºÀÌ ³·¾ÆÁý´Ï´Ù. º´, ¹°Áý ÆÑ, ÆÄ¿ìÄ¡ µîÀÇ ÇüÅ·ΠÁ¦°øµÇ¹Ç·Î ¸ð´ÏÅ͸µ°ú Á¦Á¦°¡ °£¼ÒÈ­µË´Ï´Ù. ¶ÇÇÑ ´Ùȸ Åõ¾à Æ÷ÀåÀº ¾ÈÀü¼º, Æí¸®¼º ¹× È¿À²¼ºÀ» Çâ»ó½ÃŰ¸é¼­ ¾à¹° Åõ¿© ¹× °ü¸®¿¡¼­ ³¶ºñ¿Í ½Ç¼ö¸¦ ÁÙ¿©ÁÝ´Ï´Ù.

º¹¾à Áؼö¿Í ÆíÀǼº¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Àß Á¤¸®µÇ°í ¶óº§ÀÌ ºÙÀº Æ÷ÀåÀº ȯÀÚ, ƯÈ÷ ³ëÀΰú Àå±â ÁúȯÀ» °¡Áø ȯÀÚ¿¡°Ô À¯¿ëÇÕ´Ï´Ù. Á¤È®ÇÏ°í ½Ã±â ÀûÀýÇÑ º¹¿ëÀ» º¸ÀåÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¹æ¹ýÀº ÀǾàǰ ½Ç¼ö¸¦ ÁÙÀÔ´Ï´Ù. ȯÀÚ º¹¿ë ±ÔÁ¤ Áؼö¸¦ °³¼±Çϱâ À§ÇØ °£º´Àΰú ÀÇ·á Àü¹®°¡´Â ¿©·¯ ¹ø Åõ¿©ÇÒ ¼ö ÀÖ´Â Æ÷ÀåÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ¼­ºñ½ºÀÇ Ç°Áú°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¾à±¹¿¡¼­ äÅõǴ ºóµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ´Â °ÍÀº ¾à¹° Åõ¿©¿¡ À־ Á¤È®¼º°ú È¿À²¼ºÀÇ ¿ä±¸ÀÔ´Ï´Ù.

³ôÀº Ãʱâ ÅõÀÚ ¹× ¿î¿µ ºñ¿ë

Áß¼Ò±Ô¸ð ¾à±¹¿¡¼­´Â ÀÚµ¿ Æ÷Àå Àåºñ¸¦ ¼³Ä¡ÇÏ´Â µ¥ ÇÊ¿äÇÑ ¸¹Àº ºñ¿ëÀ» Àý°¨ÇϱⰡ ¾î·Æ½À´Ï´Ù. ¿î¿µ ºñ¿ëÀº À¯Áö º¸¼ö ¹× Á÷¿ø ±³À°À¸·Î ´õ¿í Áõ°¡ÇÕ´Ï´Ù. ¸¹Àº °Ç°­ °ü¸® °³¾÷ÀǵéÀº ºñ¿ëÀÌ ¸¹ÀÌ µé±â ¶§¹®¿¡ ±âÁ¸ÀÇ Æ÷Àå ¹æ¹ýÀ» ¹ö¸®´Â °ÍÀ» ¸Á¼³À̰í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î °æÁ¦Àû Àå¾Ö´Â ÀÌ·¯ÇÑ ÃÖ÷´Ü ¼Ö·ç¼ÇÀÌ ³Î¸® äÅõǴ °ÍÀ» ¹æÇØÇÕ´Ï´Ù.

½º¸¶Æ® ±â¼ú ¹× µðÁöÅÐ °Ç°­ Ç÷§Æû°úÀÇ ÅëÇÕ

ÀÚµ¿ ¾Ë¸² ¹× ½Ç½Ã°£ ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÌ·¯ÇÑ ±â¼úÀº Åõ¿© ´©Ãâ°ú Åõ¿© ½Ç¼öÀÇ °¡´É¼ºÀ» °¨¼Ò½Ãŵ´Ï´Ù. ÇコÄÉ¾î ´ã´çÀÚ´Â ½º¸¶Æ® Æ÷Àå ¼Ö·ç¼ÇÀ» ÅëÇØ »ç¿ë µ¥ÀÌÅ͸¦ ¹ÞÀ» ¼ö ÀÖ¾î º¸´Ù È¿°úÀûÀÎ ¸ð´ÏÅ͸µ°ú °³º° Ä¡·á ¼öÁ¤ÀÌ °¡´ÉÇÕ´Ï´Ù. °ø±Þ¸ÁÀÇ È¿À²¼º°ú Àç°í °ü¸®´Â µðÁöÅÐ ¿¬°áÀ» ÅëÇØ ´õ¿í °­È­µË´Ï´Ù. ¿ø°Ý ÀǷḦ Áö¿øÇÏ´Â Áö´ÉÇü Æ÷ÀåÀÇ ¿ä±¸´Â ¿ø°Ý ÀÇ·á »ç¿ëÀÇ È®´ë·Î ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÀǾàǰÀÇ À¯Åë ¹æ¹ýÀ» Çö´ëÈ­ÇÕ´Ï´Ù.

¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ ¹× Æ÷Àå Æó±â¹° ¿ì·Á

Á¦Ç° °³¹ßÀº ±â¾÷ÀÌ ¾ö°ÝÇÑ Ç¥½Ã, Àç·á ¾ÈÀü ¹× ¿ë·® Á¤È®µµ ±ÔÁ¤À» ÁؼöÇØ¾ß ÇÏ´Â Çʿ信 µû¶ó Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ Æ÷Àå ÇüÅÂÀÇ Àû½Ã µµÀÔµµ ±ÔÁ¦ Áö¿¬¿¡ ÀÇÇØ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Æ÷Àå Æó±â¹°¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö°í Àֱ⠶§¹®¿¡ ±â¾÷Àº Áö¼Ó °¡´ÉÇÑ Àç·á¿¡ ´ëÇÑ ÅõÀÚ¸¦ °­¿äÇϰí ÀÖÀ¸¸ç Á¦Á¶ ºñ¿ëÀÌ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ´ÙÁß ¿ë·® Æ÷Àå ¼³°è´Â ¸¹Àº Àå¼Ò¿¡¼­ ÀçȰ¿ë ¹× Æó±â¿¡ °üÇÑ ±ÔÁ¦ÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿ä¼Ò°¡ °áÇÕµÇ¾î ¼öÀͼºÀ» ³·Ãß°í »õ·Î¿î °æÀïÀ» ¾ïÁ¦ÇÕ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ ´ëÀ¯ÇàÀº ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¾à¹° Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦»ê¾÷ü´Â »ç¶÷°úÀÇ Á¢ÃËÀ» ÃÖ¼ÒÈ­ÇÏ°í ¿À¿° À§ÇèÀ» ÁÙÀÌ´Â Æ÷Àå ¼Ö·ç¼ÇÀ» ã°í º´¿ø ¹× ¾à±¹¿¡¼­ ´Ùȸ Åõ¾à ½Ã½ºÅÛÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. °ø±Þ¸Á È¥¶õ°ú ¿øÀç·á ºÎÁ·À¸·Î ÀÎÇØ óÀ½¿¡´Â »ý»êÀÌ Áö¿¬µÇ¾úÁö¸¸ ¾ÈÀüÇϰí Á¶Á÷ÀûÀÎ Åõ¾àÀÌ ½Ã±ÞÇ߱⠶§¹®¿¡ ±â¼ú Çõ½Å°ú ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ°¡ ÃËÁøµÇ¾ú½À´Ï´Ù. ÆÒµ¥¹ÍÀº ¶ÇÇÑ È¯ÀÚÀÇ º¹¾à Ãæ°í¿Í ¾ÈÀü¼ºÀÇ Á߿伺À» °­Á¶ÇÏ°í ¼¼°è °Ç°­ °ü¸® ½Ã½ºÅÛ ½ÃÀå °ü·Ã¼ºÀ» ´õ¿í °­È­Çß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È º´ ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

º´ ºÎ¹®Àº ÀǾàǰ ¹× °Ç°­ °ü¸®¿¡¼­ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º´Àº Á¤È®ÇÑ Åõ¿©, Àç¹ÐºÀ¼º, ¿À¿°À¸·ÎºÎÅÍ º¸È£¸¦ Á¦°øÇϸç, ´Ù¿ëµµ ¿ëµµ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ´Ù¾çÇÑ ¾×ü ¹× °íü Á¦Á¦¿ÍÀÇ È£È¯¼ºÀÌ ½ÃÀå äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó º´¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´ µðÀÚÀΰú Áö¼Ó °¡´ÉÇÑ ¼ÒÀçÀÇ Áøº¸°¡ ½ÃÀå Á¡À¯À² È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.

¿¹Ãø±â°£ µ¿¾È °£È£½Ã¼³ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È, ÀϰüµÈ Åõ¾à °ü¸®¸¦ ÇÊ¿ä·Î ÇÏ´Â ³ëÀÎ Àα¸ Áõ°¡´Â °£º´ ½Ã¼³ ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³¿¡¼­´Â ¾à¹° Åõ¿©ÀÇ ¾ÈÀü¼º°ú Á¤È®¼ºÀÌ ¿ì¼±Çϱ⠶§¹®¿¡ ´ÙÁß µµÁî Æ÷ÀåÀº Åõ¾à ½Ç¼ö¸¦ ÁÙÀÓÀ¸·Î½á À̸¦ Áö¿øÇÕ´Ï´Ù. »çÀü Æ÷ÀåµÈ ¿ë·®Àº ½Ã°£À» Àý¾àÇϰí Á¦Á¦ °øÁ¤À» °£¼ÒÈ­ÇÏ¿© Á÷¿øÀÇ È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ±ÔÁ¦±â°üÀÌ °£º´ ÇöÀå¿¡¼­ÀÇ º¹¾à Áؼö¸¦ Áß½ÃÇÔ¿¡ µû¶ó, ÄÄÇöóÀ̾𽺠Æ÷Àå ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, Àå±â °£È£ ½Ã¼³Àº ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ Ã¤¿ëÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡ ¹× °Ç°­ °ü¸® ÀÎÇÁ¶ó È®´ë·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, ÀϺ», Àεµ µî ±¹°¡µéÀº ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ °­È­Çϰí Åõ¾à ½Ç¼ö¸¦ ÁÙÀ̱â À§ÇØ °í±Þ ÀǾàǰ Æ÷Àå ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í µðÁöÅÐ ÇコÀÇ µµÀÔ°ú ÇÔ²², ½º¸¶Æ®ÇÑ Åõ¾à °ü¸®¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡°¡ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇöÁö ±â¾÷Àº º´¿ø ¹× ÀçÅà Äɾî ȯ°æ¿¡¼­ÀÇ ¿ä±¸ Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ºñ¿ë È¿À²ÀûÀ̰í Áö¼Ó °¡´ÉÇÑ Æ÷Àå ¼Ö·ç¼ÇÀ¸·Î Àû±ØÀûÀ¸·Î ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇß½À´Ï´Ù.

°¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³»´Â Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ÀÌ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, ¼±ÁøÀûÀÎ ¾à»ç °üÇà, Á¦Á¦¿¡¼­ ÀÚµ¿È­ÀÇ °­·ÂÇÑ Ã¤¿ëÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â Çõ½ÅÀûÀÎ ºí¸®½ºÅÍ ÆÑ°ú RFID Áö¿ø Æ÷ÀåÀ» ÅëÇØ ÀǾàǰ Áؼö¸¦ ÃÖ¼ÒÈ­ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í Àå±â °£È£ ½Ã¼³, ¾ç·Î¿ø, ¿Ü·¡ ȯÀÚ ¼­ºñ½º ¼ö¿ä Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ¹× µðÁöÅРó¹æ Ç÷§Æû°úÀÇ ÅëÇÕÀÌ º¸±ÞµÇ°í ÀÖÀ¸¸ç, ´Ùȸ Åõ¾à Æ÷ÀåÀº ¾÷¹« È¿À²¼º°ú ȯÀÚ °á°ú °³¼±¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¹«·á ÁÖ¹®À» ¹Þ¾Æ¼­ ¸¸µå´Â ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ã߰衤¿¹Ãø¡¤CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç°ºÐ¼®
  • ±â¼ú ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ºí¸®½ºÅÍ ÆÑ
  • ÆÄ¿ìÄ¡
  • º´
  • ºÀÁö
  • ¹ÙÀ̾Ë
  • º´
  • Æ©ºê
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : Àç·áº°

  • ÇÃ¶ó½ºÆ½
  • Á¾ÀÌ
  • ¾Ë·ç¹Ì´½
  • À¯¸®
  • ±âŸ Àç·á

Á¦7Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : ¾àÁ¦ À¯Çüº°

  • 󹿾à
  • ÀϹÝÀǾàǰ(OTC)

Á¦8Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : À¯Åë ä³Îº°

  • ±â°ü ÆÇ¸Å
  • ¼Ò¸Å ÆÇ¸Å
  • ¿Â¶óÀÎ ¾à±¹
  • Á÷Á¢ ÀÔÂû

Á¦9Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°

  • ¼öµ¿ Æ÷Àå
  • ¹ÝÀÚµ¿ Æ÷Àå
  • ¿ÏÀü ÀÚµ¿ Æ÷Àå

Á¦10Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Àå±â ÄÉ¾î ½Ã¼³
  • ¼Ò¸Å ¾à±¹
  • ÀçÅà Äɾî ȯ°æ
  • Ŭ¸®´Ð
  • ÀçȰ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦11Àå ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Omnicell, Inc.
  • Swisslog Healthcare
  • Tosho Co., Ltd.
  • Manrex Limited
  • Becton, Dickinson and Company(BD)
  • McKesson Corporation
  • Cardinal Health, Inc.
  • Baxter International Inc.
  • Parata Systems, LLC
  • ScriptPro LLC
  • Yuyama Co., Ltd.
  • ARxIUM Inc.
  • JVM Co., Ltd.
  • Accu-Chart Plus Healthcare Systems, Inc.
  • Euclid Medical Products
KTH 25.08.18

According to Stratistics MRC, the Global Multi-Dose Packaging System Market is accounted for $3.7 billion in 2025 and is expected to reach $6.5 billion by 2032 growing at a CAGR of 8.1% during the forecast period. A pharmaceutical packaging technique called a multi-dose packaging system is made to include several doses of medication in one container. It is frequently used to increase drug adherence, especially for patients with chronic diseases and in environments like hospitals and assisted living facilities. These methods frequently arrange dosages according to date and time, which lowers the possibility of missing or giving the wrong dosage. Available in bottles, blister packs, or pouches, they simplify monitoring and dispensing. Additionally, multi-dose packaging reduces waste and mistakes in the administration and management of medications while improving safety, convenience, and efficiency.

Market Dynamics:

Driver:

Rising demand for medication adherence and convenience

Well-organised and labelled packaging is beneficial to patients, particularly the elderly and those with long-term illnesses. By guaranteeing precise and timely dosage, these methods lower pharmaceutical mistakes. For better patient compliance, carers and medical professionals favour multi-dose packs. These solutions are being adopted by pharmacies more frequently in an effort to improve service quality and safety. In general, market expansion is driven by the requirement for accuracy and efficiency in drug administration.

Restraint:

High initial investment and operational costs

Small and mid-sized pharmacies may find it difficult to afford the significant expenditure needed to set up automated packaging equipment. Operational costs are further increased by maintenance and employee training. Many healthcare practitioners are discouraged from abandoning traditional packing methods because to the hefty expenses. Consequently, there is still little market penetration, particularly in underdeveloped nations. Overall, financial obstacles prevent these cutting-edge solutions from being widely adopted.

Opportunity:

Integration with smart technologies and digital health platforms

The chance of missing or giving the wrong dose is decreased by these technologies, which allow for automated reminders and real-time tracking. Healthcare practitioners can receive usage data via smart packaging solutions, enabling more effective monitoring and individualised treatment modifications. The efficiency of the supply chain and inventory management are further enhanced by digital connectivity. The need for intelligent packaging that supports remote care is further increased by the expanding use of telemedicine. All things considered, these developments enhance patient outcomes and modernise medication distribution methods.

Threat:

Strict regulatory standards and packaging waste concerns

Product development may be slowed down by the need for businesses to adhere to strict labelling, material safety, and dosage precision regulations. The timely introduction of innovative packaging formats may also be impacted by regulatory delays. Furthermore, companies are being forced to invest in sustainable materials due to increased worries about packaging waste, which raises production costs. Existing multi-dose packaging designs are challenged by recycling and disposal regulations in many places. All of these elements work together to lower profitability and deter new competitors.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the Multi-Dose Packaging System Market by increasing demand for secure and efficient medication dispensing. Healthcare providers sought packaging solutions that minimized human contact and reduced the risk of contamination, driving the adoption of multi-dose systems in hospitals and pharmacies. Supply chain disruptions and raw material shortages initially slowed production, but the urgent need for safe, organized medication delivery fuelled innovation and investments in automation. The pandemic also emphasized the importance of patient adherence and safety, further strengthening the market's relevance in global healthcare systems.

The bottles segment is expected to be the largest during the forecast period

The bottles segment is expected to account for the largest market share during the forecast period, due to its widespread use in pharmaceuticals and healthcare. Bottles offer precise dosing, resealability, and protection from contamination, making them ideal for multi-use applications. Their compatibility with various liquid and solid formulations enhances market adoption. Growing demand for user-friendly and cost-effective packaging solutions boosts their preference. Additionally, advancements in bottle design and sustainable materials support their increasing market share.

The long-term care facilities segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the long-term care facilities segment is predicted to witness the highest growth rate, due to the rising elderly population requiring consistent medication management. These facilities prioritize safety and accuracy in drug administration, which multi-dose packaging supports by reducing medication errors. Staff efficiency improves as pre-packaged doses save time and streamlines dispensing processes. The demand for compliance packaging grows as regulatory bodies emphasize adherence in care settings. Consequently, long-term care facilities drive sustained growth in the adoption of multi-dose packaging systems.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising geriatric population, increasing prevalence of chronic diseases, and expanding healthcare infrastructure. Countries like China, Japan, and India are investing in advanced pharmaceutical packaging technologies to enhance patient compliance and reduce medication errors. Growing awareness of smart medication management, along with rapid urbanization and digital health adoption, further fuels demand. Local players are actively innovating with cost-effective and sustainable packaging solutions to cater to the rising need in hospital and homecare settings.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by stringent regulatory standards, advanced pharmaceutical practices, and strong adoption of automation in drug dispensing. The U.S. and Canada are focusing on minimizing medication non-adherence through innovative blister packs and RFID-enabled packaging. The presence of key market players and growing demand from long-term care facilities, nursing homes, and outpatient services amplify market expansion. Integration with electronic health records (EHRs) and digital prescription platforms are gaining traction, making multi-dose packaging essential for operational efficiency and improved patient outcomes.

Key players in the market

Some of the key players profiled in the Multi-Dose Packaging System Market include Omnicell, Inc., Swisslog Healthcare, Tosho Co., Ltd., Manrex Limited, Becton, Dickinson and Company (BD), McKesson Corporation, Cardinal Health, Inc., Baxter International Inc., Parata Systems, LLC, ScriptPro LLC, Yuyama Co., Ltd., ARxIUM Inc., JVM Co., Ltd., Accu-Chart Plus Healthcare Systems, Inc. and Euclid Medical Products.

Key Developments:

In May 2025, Tosho unveiled enhanced specifications for the Xana 4001U2 Advance, a high-capacity full-automatic tablet packing system. Updates included improved drug recognition accuracy, faster multi-dose dispensing, and streamlined user interface for hospital and pharmacy operations, boosting productivity while maintaining strict medication safety and traceability standards.

In May 2025, Omnicell launched a new line of RFID-enabled products called MedTrack. These are designed for perioperative and clinic settings, offering advanced automation, intelligent software workflows, and enhanced medication inventory management. The platform aims to reduce medication errors and streamline multi-dose packaging processes through automated tracking and inventory control.

In April 2025, Swisslog Healthcare's AutoPack(TM) upgrades with the U Canister and Variable Heater enhance packaging flexibility and efficiency. The U Canister holds up to 280 tablets, including irregular sizes, while the Variable Heater supports customizable package lengths (50-95 mm), streamlining cartfill and ADU workflows-crucial for addressing staff shortages and optimizing multi-dose medication delivery.

Products Covered:

  • Blister Packs
  • Pouches
  • Bottles
  • Sachets
  • Vials
  • Jars
  • Tubes
  • Other Products

Materials Covered:

  • Plastic
  • Paper
  • Aluminum
  • Glass
  • Other Materials

Drug Types Covered:

  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs

Distribution Channels Covered:

  • Institutional Sales
  • Retail Sales
  • Online Pharmacies
  • Direct Tenders

Technologies Covered:

  • Manual Packaging
  • Semi-Automated Packaging
  • Fully Automated Packaging

End Users Covered:

  • Hospitals
  • Long-term Care Facilities
  • Retail Pharmacies
  • Home Care Settings
  • Clinics
  • Rehabilitation Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Multi-Dose Packaging System Market, By Product

  • 5.1 Introduction
  • 5.2 Blister Packs
  • 5.3 Pouches
  • 5.4 Bottles
  • 5.5 Sachets
  • 5.6 Vials
  • 5.7 Jars
  • 5.8 Tubes
  • 5.9 Other Products

6 Global Multi-Dose Packaging System Market, By Material

  • 6.1 Introduction
  • 6.2 Plastic
  • 6.3 Paper
  • 6.4 Aluminum
  • 6.5 Glass
  • 6.6 Other Materials

7 Global Multi-Dose Packaging System Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription Drugs
  • 7.3 Over-the-Counter (OTC) Drugs

8 Global Multi-Dose Packaging System Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Institutional Sales
  • 8.3 Retail Sales
  • 8.4 Online Pharmacies
  • 8.5 Direct Tenders

9 Global Multi-Dose Packaging System Market, By Technology

  • 9.1 Introduction
  • 9.2 Manual Packaging
  • 9.3 Semi-Automated Packaging
  • 9.4 Fully Automated Packaging

10 Global Multi-Dose Packaging System Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Long-term Care Facilities
  • 10.4 Retail Pharmacies
  • 10.5 Home Care Settings
  • 10.6 Clinics
  • 10.7 Rehabilitation Centers
  • 10.8 Other End Users

11 Global Multi-Dose Packaging System Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Omnicell, Inc.
  • 13.2 Swisslog Healthcare
  • 13.3 Tosho Co., Ltd.
  • 13.4 Manrex Limited
  • 13.5 Becton, Dickinson and Company (BD)
  • 13.6 McKesson Corporation
  • 13.7 Cardinal Health, Inc.
  • 13.8 Baxter International Inc.
  • 13.9 Parata Systems, LLC
  • 13.10 ScriptPro LLC
  • 13.11 Yuyama Co., Ltd.
  • 13.12 ARxIUM Inc.
  • 13.13 JVM Co., Ltd.
  • 13.14 Accu-Chart Plus Healthcare Systems, Inc.
  • 13.15 Euclid Medical Products
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦